¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Infection following immunization"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • lytic infection
    ¿ë±Õ°¨¿°
  • midpalmar space infection
    Áß°£¼Õ¹Ù´Ú°ø°£°¨¿°
  • milk-borne infection
    ¿ìÀ¯¸Å°³°¨¿°
  • mixed infection
    È¥ÇÕ°¨¿°
  • mock infection
    ¸ðÀǰ¨¿°½ÇÇè
  • multiple infection
    º¹¼ö°¨¿°, ¿©·¯¹ø°¨¿°
  • mycotic infection
    °õÆÎÀ̰¨¿°, Áø±Õ°¨¿°
  • mass infection
    Áý´Ü°¨¿°
  • neonatal infection
    ½Å»ý¾Æ°¨¿°
  • nosocomial infection
    º´¿ø³»°¨¿°
  • nosocomial infection control
    º´¿ø³»°¨¿°°ü¸®
  • natural infection
    ÀÚ¿¬°¨¿°
  • occult infection
    ÀáÀç°¨¿°
  • opportunistic infection
    ±âȸ°¨¿°
  • oral infection
    ÀԾȰ¨¿°, °æ±¸°¨¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • latent infection
    Àẹ°¨¿°
  • local infection
    ±¹¼Ò°¨¿°
  • localized infection
    ±¹¼Ò°¨¿°
  • lymphogenous infection
    ¸²ÇÁ°¨¿°
  • lytic infection
    ¿ë±Õ¼º°¨¿°
  • mass infection
    Áý´Ü°¨¿°
  • midpalmar space infection
    Áß°£¼Õ¹Ù´Ú°ø°£°¨¿°
  • milk-borne infection
    ¿ìÀ¯¸Å°³°¨¿°
  • mixed infection
    È¥ÇÕ°¨¿°
  • mock infection
    ¸ðÀǰ¨¿°½ÇÇè
  • multiple infection
    ¿©·¯¹ø°¨¿°
  • mycotic infection
    Áø±Õ°¨¿°
  • natural infection
    ÀÚ¿¬°¨¿°
  • neonatal infection
    °«³­¾Ö°¨¿°, ½Å»ý¾Æ°¨¿°
  • nosocomial infection
    ¿ø³»°¨¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • hospital acquired (nosocomial) infection
    ¿ø³»°¨¿°(êÂÒ®Êïæø), º´¿ø°¨¿°.
  • hospital acquired infection
    ¿ø³»°¨¿°, º´¿ø³»°¨¿°
  • hospital infection =nosocomial i.
    ¿ø³»°¨¿°(¡­Êïæø), º´¿ø°¨¿°.
  • hospital infection =nosocomial i.
    ¿ø³»°¨¿°(¡­°¨¿°), º´¿ø°¨¿°.
  • hospital infection control
    ¿ø³»<º´¿ø>°¨¿°°ü¸®
  • huma immunodeficiency virus,follicular dendritic cell infection by
    ¿©Æ÷»ó¼öÁö¼¼Æ÷°¨¿°
  • inapparant infection
    ºÒÇö°¨¿°
  • inapparent infection
    ºÒÇö¼º °¨¿°.
  • indirect contact infection
    °£Á¢Á¢Ã˰¨¿° <Àü¿°>.
  • indirect infection
    °£Á¢°¨¿°.
  • infection
    °¨¿°(Êïæø), Àü¿°(îîæø).
  • infection
    °¨¿°
  • infection allergy
    °¨¿°(Êïæø)¾Ë·¹¸£±â.
  • infection by dirt
    ¿À¹°°¨¿°(çýÚªÊïæø).
  • infection control study
    °¨¿°°ü¸®¿¬±¸
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • disseminated fungal infection
    ÆÄÁ¾¼º Áø±Õ°¨¿°
  • disseminated gonococcal infection
    ÆÄÁ¾¼º ÀÓ±Õ°¨¿°
  • dormant infection
    Àẹ°¨¿°, È޸鰨¿°
  • dormant infection
    Àẹ°¨¿°, ÀáÀç°¨¿°, È޸鰨¿°
  • double infection
    Áߺ¹°¨¿°(ñìÜÜÊïæø).
  • droplet infection
    ºñ¸»°¨¿°(Ë×ËÎ˧Ëç).
  • droplet infection
    ºñ¸»°¨¿°(Þ«ØÈÊïæú).
  • dust infection
    ¸ÕÁö°¨¿°(ÊÙ˧Ëç).
  • dust-borne infection
    ¸ÕÁö¸Å°³°¨¿°
  • efficiency of infection (EOI)
    °¨¿°È¿À²Áö¼ö
  • endogenous infection
    ³»Àμº°¨¿°
  • enteral infection
    Àå°ü°¨¿°(íóηÊïæø).
  • enterobacter infection
    ¿£Å׷ιÚÅ׸£ °¨¿°
  • enterovirus infection
    Àå¹ÙÀÌ·¯½º°¨¿°.
  • erysipelothrix infection
    ´Üµ¶°¨¿°(Áõ), ¿¡µð½ÃÆç·ÎÆ®¸¯½º(¼Ó)°¨¿°(Áõ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
cEBV chronic Epstein-Barr virus [infection]
CI cardiac index; cardiac insufficiency; cell immunity; cell inhibition; cephalic index; cerebral infar...
DELIRIUM drugs-electrolytes-low temperature and lunacy-intoxication and intracranial processes-retention of u...
DGI dentinogenesis imperfecta; disseminated gonococcal infection
DNTM disseminated nontuberculous mycobacterial [infection]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
HCV Hepatitis C virus infection
HICPAC Hospital Infection Control Practice Advisory Committee
HIV Human immunodeficiency virus infection
HPV Human papillomavirus infection
ICP Infection Control Practitioner
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • slow virus infection
    ½½·Î¿ì ¹ÙÀÌ·¯½º °¨¿°
  • source of infection
    °¨¿°¿ø
  • staphylococcal infection
    Æ÷µµ»ó ±¸±Õ °¨¿°
  • upper respiratory infection
    »ó±âµµ °¨¿°
  • virus respiratory infection
    ¹ÙÀÌ·¯½º¼º È£Èí±â °¨¿°Áõ
  • water borne infection
    ¼öÀμº °¨¿°
  • water-borne infection
    ¼öÀμº °¨¿°, ¼öÀμº Àü¿°
  • waterborne infection
    ¼öÀμº Àü¿°º´
    ¹°
  • wound infection
    â»ó °¨¿°
  • zoonotic infection
    Àμö °øÅë °¨¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
mass infection Infection resulting from the entrance of a large number of pathogens into the circulation or tissues.
(05 Mar 2000)
Vincent's infection An acute or recurrent gingivitis of young and middle-aged adults characterised clinically by gingival erythema and pain, fetid odour, and necrosis and sloughing of interdental papillae and marginal gingiva which gives rise to a gray pseudomembrane; fever, regional lymphadenopathy, and other systemic manifestations also may be present. A fusiform bacillus and Treponema vincentii can be isolated from the gingival tissues in large numbers and are felt to play a significant but poorly defined role in the pathogenesis.
Synonym: fusospirochetal gingivitis, trench mouth, ulceromembranous gingivitis, Vincent's disease, Vincent's infection.
(05 Mar 2000)
viral infection The successful invasion, establishment and growth of viruses in the tissues of the host.
(27 Sep 1997)
reservoir of infection Living or nonliving material in or on which an infectious agent multiplies and/or develops and is dependent for its survival in nature.
(05 Mar 2000)
chronic symptomatic HIV infection This refers to an HIV infection that is characterised by signs and symptoms of HIV that are not life-threatening.
Examples include oral thrush, gingivitis, seborrheic dermatitis, molluscum contangiosum, fevers, fatigue, lymph node swelling, malaise and weight loss.
This stage can be a signal for the conversion from asymptomatic HIV disease to HIV disease (moe pronouced symptoms include joint pains). AIDS is diagnosed after HIV disease has started to manifest life-threatening oppotunistic infections (for example pneumocystis, cryptosporidium, toxoplasmosis, etc).
(27 Sep 1997)
close contact infection <epidemiology> An infection which requires close contact, other than sexual contact, between susceptible and infectious individuals, for transmission.
(05 Dec 1998)
mixed infection Infection by more than one variety of pathogenic microorganisms.
(05 Mar 2000)
whipworm infection <gastroenterology> An infection of the large intestine by Trichuris trichiura.
It may be the most common helminthic infection found in Americans returning from subtropical and tropical areas. Children and the mentally retarded have the highest rate of infection due to a general lack of sanitary habits.
The worms are 30-50 mm in length and attach themselves to the mucosa of the large intestine. Adult worms may live 4-8 years. Treatment is with mebendazole.
(27 Sep 1997)
multi-infection Mixed infection with two or more varieties of microorganisms developing simultaneously.
(05 Mar 2000)
congenital infection: torchs syndrome <radiology> T Toxoplasma, R Rubella, C Cytomegalic inclusion disease (CID, CMV), H Herpes, S Syphilis, transplacentally acquired, congenital infection, celery-stalk metaphyses, especially long bones, intracranial calcification, decreased growth, vascular stenosis (aorta, pulmonary artery)
(12 Dec 1998)
multiple infection <epidemiology> An infection in which an individual is infected by parasites of more than one species.
(05 Dec 1998)
wound infection Invasion of the site of trauma by pathogenic microorganisms.
(12 Dec 1998)
mycobacterium avium-intracellulare infection Nontuberculous infection occurring in humans. This condition is frequently associated with pulmonary disease and recently recognised as an opportunistic infection in aids patients.
(12 Dec 1998)
cross infection <microbiology> Infection transmitted between individuals infected with different pathogenic microorganisms. Any infection which a patient contracts in a health-care institution.
(12 Dec 1998)
cryptogenic infection Bacterial, viral, or other infection, the source of which is unknown.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á